Previous close | 1.3500 |
Open | 2.0500 |
Bid | 0.0000 x 0 |
Ask | 0.0000 x 0 |
Day's range | 1.3500 - 2.3900 |
52-week range | 1.3500 - 2.3900 |
Volume | |
Avg. volume | N/A |
Market cap | N/A |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 4.00 |
WINTERVILLE, N.C., April 10, 2024--NantHealth, Inc. (NASDAQ-GS: NH), proudly announces the expansion of its product leadership team by appointing three seasoned executives who will spearhead efforts to integrate innovation, automation, and artificial intelligence into the company's product offerings. This strategic move underscores NantHealth's unwavering commitment to revolutionizing healthcare technology and delivering excellence to its customers.